Product
Saxenda
3 clinical trials
3 indications
Indication
ObesityIndication
infertilityIndication
WomanClinical trial
A Phase 2, Open-label, Randomised, Dose-Finding Study of XW003, Once-Weekly Human Glucagon-Like Peptide 1 Analogue, Compared With Once-Daily Liraglutide 3 mg in Adult Participants With ObesityStatus: Completed, Estimated PCD: 2022-11-16
Clinical trial
Effect of GLP-1 Receptor Agonism on Weight and Caloric Intake in Subjects After Sleeve GastrectomyStatus: Active (not recruiting), Estimated PCD: 2023-10-04
Clinical trial
Investigation of the Metabolic Effects of 3mg Liraglutide on Patients With Overweight or ObesityStatus: Completed, Estimated PCD: 2020-12-18